Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3082866 26 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Does subclinical hypercortisolism adversely affect the bone mineral
density of patients with adrenal incidentalomas?
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
OBJECTIVE Subclinical hypercortisolism (SH) is detected increasingly in
a substantial proportion of patients with incidentally discovered
adrenal adenomas. The clinical implications of SH are currently unclear.
Osteoporosis is a well-known complication of glucocorticoid excess. So
far, the impact of SH on bone mineral density (BMD) has been studied in
a limited number of reports with discordant results. In the present
study we evaluated the BMD in a large cohort of post-menopausal women
with adrenal incidentalomas.
PATIENTS AND MEASUREMENTS Forty-two post-menopausal women with
incidentally discovered adrenal masses and radiological features highly
suggestive of benign adrenal adenomas were investigated. All patients
underwent a standard low-dose dexamethasone suppression test (LDDST; 0.5
mg 6-hourly for 2 days). The diagnosis of subclinical hypercortisolism
(SH) was based on post-LDDST cortisol concentrations of >70 nmol/l.
According to this criterion patients were subdivided into two groups:
with (n = 18; group A) or without (n = 24; group B) SH. There was no
significant difference in age, years since menopause and body mass index
between these groups. BMD was measured at L2-L4 vertebrae and three
sites of the proximal femur by the dual energy X-ray absorptiometry
(DEXA) method.
RESULTS Post-menopausal women with SH (group A) exhibited slightly but
significantly lower absolute and age-adjusted BMD values compared to
group B patients in the femoral neck (BMD g/cm(2): 0.72 +/- 0.08 vs.
0.79 +/- 0.09; Z -score: -0.20 +/- 0.82 vs. +0.43 +/- 0.94, P < 0.05)
and trochanter (BMD g/cm(2): 0.60 +/- 0.09 vs. 0.69 +/- 0.10; Z-score:
-0.32 +/- 1.0 vs. +0.30 +/- 1.05, P < 0.01). BMD measurements of the
Ward’s triangle were also lower in group A patients but the difference
did not reach statistical significance (BMD g/cm(2): 0.60 +/- 0.10 vs.
0.68 +/- 0.13, P = 0.06). There was no difference in the lumbar
vertebrae between the two groups (BMD g/cm(2): 0.888 +/- 0.13 vs. 0.90
+/- 0.16, P = 0.78; z-score: +0.50 +/- 1.16 vs. +0.11 +/- 1.5, P =
0.36). The number of patients in the osteoporotic range was minimal with
no significant difference between the two groups. However, the frequency
of osteopenia in group A was significantly greater than in group B
patients in the trochanter and Ward’s triangle areas. Serum osteocalcin
(BGP) levels were significantly lower in group A compared to group B
patients (18.6 +/- 8.6 vs. 26.2 +/- 8.1 ng/ml, P < 0.01); no difference
existed regarding parathyroid hormone (PTH) concentrations (43 +/- 15.6
vs. 41.2 +/- 14.8 pg/ml, P = 0.72).
CONCLUSIONS In this series, post-menopausal women with subclinical
hypercortisolism had lower absolute and age-adjusted BMD values and a
higher rate of osteopaenia in the trabecular loaded and mixed
cortical-trabecular bone of proximal femur. These data demonstrate that
the subtle hypercortisolism of patients with adrenal incidentalomas may
have an adverse effect on the bone mass of these patients.
Έτος δημοσίευσης:
2003
Συγγραφείς:
Hadjidakis, D
Tsagarakis, S
Roboti, C
Sfakianakis, M and
Iconomidou, V
Raptis, SA
Thalassinos, N
Περιοδικό:
Clinical Endocrinology
Εκδότης:
Wiley-Blackwell Publishing Ltd
Τόμος:
58
Αριθμός / τεύχος:
1
Σελίδες:
72-77
Επίσημο URL (Εκδότης):
DOI:
10.1046/j.1365-2265.2003.01676.x
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.